Publication:
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections

Simple item page
dc.contributor.buuauthorYılmaz, Emel
dc.contributor.buuauthorAkalın, Halis
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-3894-1231tr_TR
dc.contributor.researcheridAAU-8952-2020tr_TR
dc.contributor.scopusid22037135100tr_TR
dc.contributor.scopusid57207553671tr_TR
dc.date.accessioned2024-03-05T11:36:42Z
dc.date.available2024-03-05T11:36:42Z
dc.date.issued2018-03
dc.descriptionÇalışmada 31 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştırtr_TR
dc.description.abstractThis article describes the emergence of resistance and predictors of fatality for 1556 cases of healthcare-associated Gram-negative bloodstream infection in 2014 and 2015. The colistin resistance rate in Klebsiella pneumoniae was 16.1%, compared with 6% in 2013. In total, 660 (42.4%) cases were fatal. The highest fatality rate was among patients with Acinetobacter baumannii bacteraemia (58%), followed by Pseudomonas aeruginosa (45%), Klebsiella pneumoniae (41%), Enterobacter cloacae (32%) and Escherichia coli (28%). On multi-variate analysis, the minimum inhibitory concentrations for carbapenems [odds ratio (OR) 1.02, 95% confidence interval (CI) 1.01-1.04; P = 0.002] and colistin (OR 1.1, 95% CI 1.03-1.17; P = 0.001) were found to be significantly associated with fatality.en_US
dc.identifier.citationAydın, M. vd. (2018). ''Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections''. Journal of Hospital Infection, 98(3), 260-263.en_US
dc.identifier.doihttps://doi.org/10.1016/j.jhin.2017.11.014
dc.identifier.endpage263tr_TR
dc.identifier.issn0195-6701
dc.identifier.issn1532-2939
dc.identifier.issue3tr_TR
dc.identifier.pubmed29248504tr_TR
dc.identifier.scopus2-s2.0-85044363955tr_TR
dc.identifier.startpage260tr_TR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0195670117306412
dc.identifier.urihttps://hdl.handle.net/11452/40219
dc.identifier.volume98tr_TR
dc.identifier.wos000426316700011
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherW.B. Saundersen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalJournal of Hospital Infectionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPublic, environmental & occupational healthen_US
dc.subjectInfectious diseasesen_US
dc.subjectBloodstreamen_US
dc.subjectGram-negativeen_US
dc.subjectHealth careen_US
dc.subjectColistin MICen_US
dc.subject.emtreeCarbapenem derivativeen_US
dc.subject.emtreeColistinen_US
dc.subject.emtreeAntiinfective agenten_US
dc.subject.emtreeCarbapenem derivativeen_US
dc.subject.emtreeColistinen_US
dc.subject.emtreeAcinetobacter baumanniien_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAntibiotic resistanceen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBacteremiaen_US
dc.subject.emtreeBloodstream infectionen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeEnterobacter cloacaeen_US
dc.subject.emtreeEscherichia colien_US
dc.subject.emtreeFatalityen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHealthcare associated infectionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKlebsiella pneumoniaeen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMinimum inhibitory concentrationen_US
dc.subject.emtreeMortality rateen_US
dc.subject.emtreePseudomonas aeruginosaen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeCross infectionen_US
dc.subject.emtreeGram negative bacteriumen_US
dc.subject.emtreeGram negative infectionen_US
dc.subject.emtreeIsolation and purificationen_US
dc.subject.emtreeMicrobial sensitivity testen_US
dc.subject.emtreeMicrobiologyen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreeVery elderlyen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshAnti-bacterial agentsen_US
dc.subject.meshBacteremiaen_US
dc.subject.meshCarbapenemsen_US
dc.subject.meshColistinen_US
dc.subject.meshCross infectionen_US
dc.subject.meshFemaleen_US
dc.subject.meshGram-negative bacteriaen_US
dc.subject.meshGram-negative bacterial infectionsen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMicrobial sensitivity testsen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshRetrospective studiesen_US
dc.subject.scopusColistin; Escherichia Coli; Resistance Genesen_US
dc.subject.wosPublic, environmental & occupational healthen_US
dc.subject.wosInfectious diseasesen_US
dc.titleRapid emergence of colistin resistance and its impact on fatality among healthcare-associated infectionsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
PubMed
Scopus